0001093557-20-000260.txt : 20200916
0001093557-20-000260.hdr.sgml : 20200916
20200916164432
ACCESSION NUMBER: 0001093557-20-000260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200916
DATE AS OF CHANGE: 20200916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Balo Andrew K
CENTRAL INDEX KEY: 0001323190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 201179268
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 5555 OBERLIN DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-09-15
0
0001093557
DEXCOM INC
DXCM
0001323190
Balo Andrew K
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
*
Common Stock
2020-09-15
4
S
0
5256
397.3535
D
35567
D
On December 11, 2019, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
*EVP Regulatory Strategy Clinical Affairs and Strategic Partnership Development
By: Jereme Sylvain For: Andrew K Balo
2020-09-16